Literature DB >> 8857485

Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation.

E Arbustini1, B Dal Bello, P Morbini, M Grasso, M Diegoli, R Fasani, A Pilotto, O Bellini, C Pellegrini, L Martinelli, C Campagna, A Gavazzi, G Specchia, M Viganò, W C Roberts.   

Abstract

We investigated at autopsy or at retransplantation the frequency and characteristics of coronary thrombosis in 76 cardiac allografts: 37 in place for < or = 2 months (early) and 39 in place >2 to 99 months (late). The 76 allografts were inserted in 69 patients: a single 1 in 56 patients and 2 allografts in 13 patients, 7 of whom subsequently died and had an autopsy. An average of 140 sections from 70 5-mm-long segments of 8 epicardial coronary arteries were examined from each of the 76 allografts with both hematoxylin-eosin and Movat pentachrome stains. Thrombus was found in only 1 coronary artery (3%) (the right one) of the 37 early allografts, and in 24 of 39 late allografts (61%). Of the latter 39 grafts, 29 (79%) had allograft vascular disease (AVD) and 24 (83%) of them had coronary thrombosis. Of the 312 epicardial coronary arteries (4 major and 4 minor) examined in the 39 late cases, 66 arteries (21%) contained thrombus. Of the 24 late cases with thrombus in at least 1 artery, thrombus was present in 66 (34%) of the 192 epicardial coronary arteries examined: in 6 of the 8 arteries in 3 patients; in 5 arteries in 2 patients; in 4 arteries in 1 patient; in 3 arteries in 5 patients; in 2 arteries in 6 patients, and in a single artery in 7 patients. In all 66 arteries with thrombus (24 patients) the thrombus was longer than 5 mm. The thrombus in the late cases was entirely nonocclusive (mural) in 51 (77%) of the 66 epicardial coronary arteries containing thrombus and entirely occlusive in 10 arteries (15%). It consisted exclusively of multiluminal channels in 6 arteries (9%) and combinations in 1 artery (2%). Acute myocardial infarcts were present in 3 patients, all of whom had occlusive thrombi. In all 10 arteries with occlusive thrombi, the thrombus was larger than the underlying plaque and no occlusive thrombi were located over ulcerated plaques. These observations demonstrate that thrombus is common in epicardial coronary arteries >2 months after cardiac transplantation.

Entities:  

Mesh:

Year:  1996        PMID: 8857485     DOI: 10.1016/s0002-9149(96)00424-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

1.  ST Elevation Myocardial Infarction Early After Heart Transplantation.

Authors:  Sérgio Lourenço Madeira; Luís Filipe Raposo; Márcio Madeira; Marta Marques; Maria José Rebocho; José Pedro Neves
Journal:  Arq Bras Cardiol       Date:  2015-07-01       Impact factor: 2.000

2.  William Clifford Roberts, MD: an interview by W. Bruce Fye, MD.

Authors:  William C Roberts; W Bruce Fye
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-07

3.  Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.

Authors:  Andrew Cassar; Yoshiki Matsuo; Joerg Herrmann; Jing Li; Ryan J Lennon; Rajiv Gulati; Lilach O Lerman; Sudhir S Kushwaha; Amir Lerman
Journal:  Eur Heart J       Date:  2013-06-25       Impact factor: 29.983

4.  Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction.

Authors:  Sergio A Torres; Omar Cheema; Dipan J Shah; Guillermo Torre-Amione; Jerry D Estep
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

5.  Long-term outcomes of heart transplantation recipients with transplant coronary artery disease who develop in-stent restenosis after percutaneous coronary intervention.

Authors:  Michael S Lee; Richard K Cheng; David E Kandzari; Ajay J Kirtane
Journal:  Am J Cardiol       Date:  2012-03-31       Impact factor: 2.778

Review 6.  Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis.

Authors:  Boško Skorić; Maja Čikeš; Jana Ljubas Maček; Željko Baričević; Ivan Škorak; Hrvoje Gašparović; Bojan Biočina; Davor Miličić
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.